IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3139-3151

  Zhu, Bing ^a   Buttrick, Thomas ^a   Bassil, Ribal ^a   Zhu, Chen ^a   Olah, Marta ^a   Wu, Chuan ^a   Xiao, Sheng ^a   Orent, William ^a   Elyaman, Wassim ^a   Khoury, Samia J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE1A2; CD103 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; RETINOIC ACID; STAT6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; TRETINOIN;

EID: 84884248504     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300329     Document Type: Article

References (60)

1. Geissmann, F., C. Auffray, R. Palframan, C. Wirrig, A. Ciocca, L. Campisi, E. Narni-Mancinelli, and G. Lauvau. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of Tcell responses. Immunol. Cell Biol. 86: 398-408.
2. Shi, C., and E. G. Pamer. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11: 762-774.
3. Sunderkötter, C., T. Nikolic, M. J. Dillon, N. Van Rooijen, M. Stehling, D. A. Drevets, and P. J. Leenen. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172: 4410-4417.
4. Zhu, B., Y. Bando, S. Xiao, K. Yang, A. C. Anderson, V. K. Kuchroo, and S. J. Khoury. 2007. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179: 5228-5237.
5. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
6. Campbell, I. K., A. van Nieuwenhuijze, E. Segura, K. O'Donnell, E. Coghill, M. Hommel, S. Gerondakis, J. A. Villadangos, and I. P. Wicks. 2011. Differentiation of inflammatory dendritic cells is mediated by NF-kB1-dependent GMCSF production in CD4 T cells. J. Immunol. 186: 5468-5477.
7. Rivollier, A., J. He, A. Kole, V. Valatas, and B. L. Kelsall. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209: 139-155.
8. Zhu, B., J. K. Kennedy, Y. Wang, C. Sandoval-Garcia, L. Cao, S. Xiao, C. Wu, W. Elyaman, and S. J. Khoury. 2011. Plasticity of Ly-6C(hi) myeloid cells in T cell regulation. J. Immunol. 187: 2418-2432.
9. King, I. L., T. L. Dickendesher, and B. M. Segal. 2009. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113: 3190-3197.
10. Steinman, R. M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449: 419-426.
11. Thomson, A. W. 2010. Tolerogenic dendritic cells: all present and correct? Am. J. Transplant. 10: 214-219.
12. Pulendran, B., H. Tang, and S. Manicassamy. 2010. Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat. Immunol. 11: 647-655.
13. Belkaid, Y., and G. Oldenhove. 2008. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29: 362-371.
14. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
15. Sun, C. M., J. A. Hall, R. B. Blank, N. Bouladoux, M. Oukka, J. R. Mora, and Y. Belkaid. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204: 1775-1785.
16. Ahrendt, M., S. I. Hammerschmidt, O. Pabst, R. Pabst, and U. Bode. 2008. Stromal cells confer lymph node-specific properties by shaping a unique microenvironment influencing local immune responses. J. Immunol. 181: 1898-1907.
17. Peron, J. P., A. P. de Oliveira, and L. V. Rizzo. 2009. It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun. Rev. 9: 1-4.
18. Laffont, S., K. R. Siddiqui, and F. Powrie. 2010. Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. Eur. J. Immunol. 40: 1877-1883.
19. Strauch, U. G., N. Grunwald, F. Obermeier, S. Gürster, and H. C. Rath. 2010. Loss of CD103+ intestinal dendritic cells during colonic inflammation. World J. Gastroenterol. 16: 21-29.
20. Benson, M. J., K. Pino-Lagos, M. Rosemblatt, and R. J. Noelle. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204: 1765-1774.
21. Elias, K. M., A. Laurence, T. S. Davidson, G. Stephens, Y. Kanno, E. M. Shevach, and J. J. O'Shea. 2008. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020.
22. Kang, S. G., H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim. 2007. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179: 3724-3733.
23. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
24. Schambach, F., M. Schupp, M. A. Lazar, and S. L. Reiner. 2007. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37: 2396-2399.
25. Zhou, X., N. Kong, J. Wang, H. Fan, H. Zou, D. Horwitz, D. Brand, Z. Liu, and S. G. Zheng. 2010. Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J. Immunol. 185: 2675-2679.
26. Xiao, S., H. Jin, T. Korn, S. M. Liu, M. Oukka, B. Lim, and V. K. Kuchroo. 2008. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181: 2277-2284.
27. Massacesi, L., A. L. Abbamondi, C. Giorgi, F. Sarlo, F. Lolli, and L. Amaducci. 1987. Suppression of experimental allergic encephalomyelitis by retinoic acid. J. Neurol. Sci. 80: 55-64.
28. Massacesi, L., E. Castigli, M. Vergelli, J. Olivotto, A. L. Abbamondi, F. Sarlo, and L. Amaducci. 1991. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J. Clin. Invest. 88: 1331-1337.
29. Racke, M. K., D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis: IL-4 production correlates with improved disease course. J. Immunol. 154: 450-458.
30. Keino, H., T. Watanabe, Y. Sato, and A. A. Okada. 2010. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis. Br. J. Ophthalmol. 94: 802-807.
31. Ohyanagi, N., M. Ishido, F. Suzuki, K. Kaneko, T. Kubota, N. Miyasaka, and T. Nanki. 2009. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo. Arthritis Rheum. 60: 3118-3127.
32. Bai, A., N. Lu, Y. Guo, Z. Liu, J. Chen, and Z. Peng. 2009. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J. Leukoc. Biol. 86: 959-969.
33. Collins, C. B., C. M. Aherne, D. Kominsky, E. N. McNamee, M. D. Lebsack, H. Eltzschig, P. Jedlicka, and J. Rivera-Nieves. 2011. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Gastroenterology 141: 1821-1831.
34. Kang, S. G., C. Wang, S. Matsumoto, and C. H. Kim. 2009. High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation. Gastroenterology 137: 1391-1402.e1-6.
35. Kwok, S. K., M. K. Park, M. L. Cho, H. J. Oh, E. M. Park, D. G. Lee, J. Lee, H. Y. Kim, and S. H. Park. 2012. Retinoic acid attenuates rheumatoid inflammation in mice. J. Immunol. 189: 1062-1071.
36. Stosić-Grujicić, S., T. Cvjetićanin, and I. Stojanović. 2009. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. Mol. Immunol. 47: 79-86.
37. Van, Y. H., W. H. Lee, S. Ortiz, M. H. Lee, H. J. Qin, and C. P. Liu. 2009. Alltrans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells. Diabetes 58: 146-155.
38. Hall, J. A., J. R. Grainger, S. P. Spencer, and Y. Belkaid. 2011. The role of retinoic acid in tolerance and immunity. Immunity 35: 13-22.
39. Feng, T., Y. Cong, H. Qin, E. N. Benveniste, and C. O. Elson. 2010. Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid. J. Immunol. 185: 5915-5925.
40. Yokota, A., H. Takeuchi, N. Maeda, Y. Ohoka, C. Kato, S. Y. Song, and M. Iwata. 2009. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int. Immunol. 21: 361-377.
41. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
42. Wu, X., Y. Yoo, N. N. Okuhama, P. W. Tucker, G. Liu, and J. L. Guan. 2006. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat. Cell Biol. 8: 756-763.
43. Guadix, J. A., A. Ruiz-Villalba, L. Lettice, V. Velecela, R. Muñoz-Chápuli, N. D. Hastie, J. M. Pérez-Pomares, and O. M. Martínez-Estrada. 2011. Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2. Development 138: 1093-1097.
44. Tzimas, G., R. Thiel, I. Chahoud, and H. Nau. 1997. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat. Toxicol. Appl. Pharmacol. 143: 436-444.
45. Goenka, S., and M. H. Kaplan. 2011. Transcriptional regulation by STAT6. Immunol. Res. 50: 87-96.
46. Theodosiou, M., V. Laudet, and M. Schubert. 2010. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell. Mol. Life Sci. 67: 1423-1445.
47. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Röcken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180: 1961-1966.
48. Scott, C. L., A. M. Aumeunier, and A. M. Mowat. 2011. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol. 32: 412-419.
49. Elgueta, R., F. E. Sepulveda, F. Vilches, L. Vargas, J. R. Mora, M. R. Bono, and M. Rosemblatt. 2008. Imprinting of CCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells. J. Immunol. 180: 6501-6507.
50. de Thé, H., M. M. Vivanco-Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177-180.
51. Hoffmann, B., J. M. Lehmann, X. K. Zhang, T. Hermann, M. Husmann, G. Graupner, and M. Pfahl. 1990. A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter. Mol. Endocrinol. 4: 1727-1736.
52. Sun, S. Y., H. Wan, P. Yue, W. K. Hong, and R. Lotan. 2000. Evidence that retinoic acid receptor beta induction by retinoids is important for tumor cell growth inhibition. J. Biol. Chem. 275: 17149-17153.
53. Swift, C. B., J. L. Hays, and W. J. Petty. 2008. Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapy. Endocr. Metab. Immune Disord. Drug Targets 8: 47-50.
54. Gong, M., Y. Bi, W. Jiang, Y. Zhang, L. Chen, N. Hou, J. Chen, and T. Li. 2013. Retinoic acid receptor beta mediates all-trans retinoic acid facilitation of mesenchymal stem cells neuronal differentiation. Int. J. Biochem. Cell Biol. 45: 866-875.
55. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
56. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
57. Manicassamy, S., and B. Pulendran. 2011. Dendritic cell control of tolerogenic responses. Immunol. Rev. 241: 206-227.
58. Schwartz, M., I. Cohen, O. Lazarov-Spiegler, G. Moalem, and E. Yoles. 1999. The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair. J. Mol. Med. 77: 713-717.
59. Uccelli, A., A. Laroni, and M. S. Freedman. 2011. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol. 10: 649-656.
60. DePaolo, R. W., V. Abadie, F. Tang, H. Fehlner-Peach, J. A. Hall, W. Wang, E. V. Marietta, D. D. Kasarda, T. A. Waldmann, J. A. Murray, et al. 2011. Coadjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471: 220-224.